SCHEMBL5067747

SCHEMBL5067747

O=[N+]([O-])c1cc(OCCc2ccccc2)ccc1Cl

nearest known ligand 0.54

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PIN1 Q13526 3/20 0.54
SMN1; SMN2 Q16637 1/20 0.52
VCAM1 P19320 3/20 0.49
CYP11B1 P15538 2/20 0.48
CYP11B2 P19099 2/20 0.48
GPR84 Q9NQS5 2/20 0.47
MAOA P21397 4/20 0.47
MAOB P27338 4/20 0.47
CA12 O43570 1/20 0.47
CA1 P00915 1/20 0.47
CA2 P00918 1/20 0.47
CA7 P43166 1/20 0.47
CA9 Q16790 1/20 0.47
NPC1 O15118 1/20 0.45
RAB9A P51151 1/20 0.45
FFAR1 O14842 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4382272 0.86 MAOA (0.49) PIN1SMN1; SMN2VCAM1GPR84MAOA
SCHEMBL4976601 0.86 GPR84 (0.46) PIN1SMN1; SMN2VCAM1GPR84MAOA
SCHEMBL810842 0.86 MEN1 (0.53) PIN1SMN1; SMN2VCAM1MAOAMAOB
SCHEMBL29463873 0.86 MEN1 (0.53) PIN1SMN1; SMN2VCAM1MAOAMAOB
SCHEMBL18702745 0.83 CA12 (0.50) PIN1CYP11B1CYP11B2MAOAMAOB
SCHEMBL29502991 0.83 MAPT (0.51) PIN1SMN1; SMN2CYP11B1CYP11B2MAOA
SCHEMBL18702665 0.83 MAPT (0.51) PIN1SMN1; SMN2CYP11B1CYP11B2MAOA
SCHEMBL4976607 0.82 GPR84 (0.41) SMN1; SMN2VCAM1GPR84NPC1RAB9A
SCHEMBL7206840 0.81 MAPT (0.47) VCAM1
SCHEMBL8127404 0.81 KDM4E (0.59) SMN1; SMN2CYP11B1CYP11B2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1971611-B1 ANTI-VIRAL COMPOUNDS ABBOTT LAB (US) 2012-10-10 EP disclosed
EP-1971611-A1 ANTI-VIRAL COMPOUNDS Abbott Laboratories (US) 2008-09-24 EP disclosed
WO-2007081517-A2 ANTI-VIRAL COMPOUNDS ABBOTT LABORATORIES (US) 2007-07-19 WO disclosed